Zivo Bioscience, Inc. (ZIVO)
SEC fundamentals · as filed in 10-Q FY2025, period ended Sep 30, 2025 · updated Oct 17, 2026
as filed in 10-Q FY2025, period ended Sep 30, 2025 · View filings on EDGAR ↗
In its 10-Q for the period ended Sep 30, 2025, Zivo Bioscience, Inc. reported revenue of $65,625, net income of -$1.0M, and total assets of $559,452. Every figure below is taken directly from Zivo Bioscience, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2015–FY2024 · as reported
- FY2015 revenue
- $0
- FY2024 revenue
- $157,220
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2024 | $157,220 | -$13.4M |
| FY2023 | $27,650 | -$7.8M |
| FY2022 | $0 | -$8.7M |
| FY2021 | $0 | -$8.8M |
| FY2020 | $20,000 | -$9.1M |
| FY2019 | $0 | -$11.5M |
| FY2018 | $0 | -$14.6M |
| FY2017 | $0 | -$10.0M |
| FY2016 | $0 | -$6.1M |
| FY2015 | $0 | -$5.8M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Mar 30, 2026 | on EDGAR ↗ |
| 8-K | Dec 23, 2025 | on EDGAR ↗ |
| 10-Q | Nov 14, 2025 | on EDGAR ↗ |
| 8-K | Sep 10, 2025 | on EDGAR ↗ |
| 8-K | Aug 18, 2025 | on EDGAR ↗ |
| 10-Q | Aug 14, 2025 | on EDGAR ↗ |
| 8-K | Jul 14, 2025 | on EDGAR ↗ |
| 8-K | Jun 11, 2025 | on EDGAR ↗ |
| 10-Q | May 15, 2025 | on EDGAR ↗ |
| DEF 14A | Apr 25, 2025 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2025 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2025
| Revenue | $65,625 | Revenue | source ↗ |
| Net Income | -$1.0M | Net | source ↗ |
| Operating Income | -$1.0M | Operating | source ↗ |
| Gross Profit | $21,288 | Gross | source ↗ |
| Cost of Revenue | $44,337 | Cost | source ↗ |
| R&D Expense | $203,444 | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2025
| EPS (diluted) | $-0.27 | Earnings | source ↗ |
| EPS (basic) | — | — | source ↗ |
| Shares Outstanding | 3.9M | Entity | source ↗ |
| Cash from Operations | -$266,556 | Net | source ↗ |
| Cash from Financing | $313,955 | Net | source ↗ |
| Cash from Investing | $0 | Net | source ↗ |
Restatement history
Point-in-time12 of 330 annual fact-keys were materially restated between filings: what Zivo Bioscience, Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches ZIVO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ZIVO
MCP tool:
get_sec_fundamentals ticker=ZIVO - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ZIVO/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=ZIVO as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/ZIVO/history
MCP tool:
get_fundamentals_history ticker=ZIVO - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/ZIVO
MCP tool:
get_financial_health ticker=ZIVO
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.